Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA – Get Rating) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 130,100 shares, a decline of 58.0% from the April 30th total of 310,100 shares. Based on an average daily volume of 1,020,000 shares, the days-to-cover ratio is […]
Satsuma Pharmaceuticals (NASDAQ:STSA – Get Rating)‘s stock had its “neutral” rating reaffirmed by stock analysts at Mizuho in a research note issued on Thursday, Benzinga reports. They presently have a $2.00 price target on the financial services provider’s stock. Mizuho’s price target indicates a potential upside of 180.62% from the stock’s previous close. Satsuma Pharmaceuticals […]